Cargando…

High-grade heart block associated with ibrutinib therapy

Detalles Bibliográficos
Autores principales:	Vartanov, Alexander R., Lampson, Benjamin L., Jacobsen, Eric D., Alyea, Edwin P., Moslehi, Javid J., Brown, Jennifer R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226304/ https://www.ncbi.nlm.nih.gov/pubmed/34194987 http://dx.doi.org/10.1016/j.hrcr.2021.03.013

Ejemplares similares

Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19
por: Hundal, Jasmin, et al.
Publicado: (2022)

Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review
por: Vartanov, Alexander, et al.
Publicado: (2021)

Ibrutinib: Grade 3 neutropenia and fever: case report
Publicado: (2022)

Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
por: O'Brien, Susan M., et al.
Publicado: (2019)

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
por: Brown, Jennifer R., et al.
Publicado: (2018)

Heart Failure and Breast Cancer Therapies: Moving Towards Personalized Risk Assessment
por: Francis, Sanjeev A., et al.
Publicado: (2014)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
por: Brown, Jennifer R., et al.
Publicado: (2017)

A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib
por: Karvaly, Gellért Balázs, et al.
Publicado: (2022)

Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy
por: Miatech, Jennifer L., et al.
Publicado: (2020)

Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia
por: Arthurs, Benjamin, et al.
Publicado: (2017)

Isolated Cardiac Sarcoidosis with High-Grade Heart Block: Utilization of New Diagnostic Guidelines
por: Petersen, Matthew R., et al.
Publicado: (2021)

Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy
por: Khaja, Misbahuddin, et al.
Publicado: (2022)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing
por: Gray, Heidi J., et al.
Publicado: (2023)

Arrhythmia Patterns in Patients on Ibrutinib
por: Fazal, Muhammad, et al.
Publicado: (2022)

Multifocal periungual granulation tissue related to ibrutinib therapy
por: Shah, Aatman, et al.
Publicado: (2020)

Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019)

Extrahepatic metabolism of ibrutinib
por: Rood, Johannes J. M., et al.
Publicado: (2020)

Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
por: Nicolson, Phillip L.R., et al.
Publicado: (2018)

Ibrutinib: Rebound effect in the form of respiratory deterioration following the discontinuation of ibrutinib: case report
Publicado: (2021)

Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection
por: Dousa, Khalid M, et al.
Publicado: (2018)

Ibrutinib combinations in CLL therapy: scientific rationale and clinical results
por: Timofeeva, Natalia, et al.
Publicado: (2021)

The Development of Multiple Periprosthetic Joint Infections in Conjunction With Ibrutinib Therapy
por: Muttana, Swathi, et al.
Publicado: (2021)

The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy
por: Mascarella, Marco A., et al.
Publicado: (2019)

Ibrutinib for B cell malignancies
por: Novero, Aileen, et al.
Publicado: (2014)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Ibrutinib: Pneumonitis: case report
Publicado: (2021)

Vascular medicine and cardio-oncology – A new, evolving clinical frontier
por: Versmissen, Jorie, et al.
Publicado: (2020)

A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy
por: Eichenberger, Emily M., et al.
Publicado: (2019)

Targets for Ibrutinib Beyond B Cell Malignancies
por: Berglöf, A., et al.
Publicado: (2015)

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
por: Landau, Dan A., et al.
Publicado: (2017)

Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
por: Voshtina, Ensi, et al.
Publicado: (2018)

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
por: Nyga, Rémy, et al.
Publicado: (2019)

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia
por: Lutz, Mathias, et al.
Publicado: (2017)

The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy
por: Ujjani, Chaitra, et al.
Publicado: (2020)

A Novel Finding of Lichenoid Drug Reaction From Ibrutinib Therapy
por: Reji, Merin, et al.
Publicado: (2022)

Recurrent Cellulitis Revealing Helicobacter cinaedi in Patient on Ibrutinib Therapy, France
por: Roupie, Anne-Laure, et al.
Publicado: (2023)

A Patient with Non-Hodgkin Lymphoma and Nonspecific Interstitial Pneumonia during Ibrutinib Therapy
por: Jungmann, Sven, et al.
Publicado: (2017)

Cardio-Oncology: Time to Get More Mechanistic
por: Moslehi, Javid, et al.
Publicado: (2017)

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
por: Moslehi, Javid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ucl5mqr8ba59j20b15uh9g1a0